Concepedia

Author

Richard Hajdu

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

R Hajdu, R. Hajdu, Richard Hajdu

37

Publications

4.1K

Citations

24

H-Index

67

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)
RH

About

Richard Hajdu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

23

2.8K

2

Natural Sciences

7

7

384

3

Health Sciences

5

5

285

4

Engineering

2

2

87

5

Allergy

1

1

1.7K

Richard Hajdu

×

29

Publications

4.1K

Citations

24

H-Index

YearCitations

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom,

Science

2002

1.7K

Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720

María L. Allende, Teiji Sasaki, Hiromichi Kawai,

Journal of Biological Chemistry

2004

443

Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

H Kropp, Jon G. Sundelof, Richard Hajdu,

Antimicrobial Agents and Chemotherapy

1982

338

Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

M J Forrest, S.-Y. Sun, Richard Hajdu,

Journal of Pharmacology and Experimental Therapeutics

2004

332

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

Richard Hajdu, R Thompson, Jon G. Sundelof,

Antimicrobial Agents and Chemotherapy

1997

167

Imipenem cross-reactivity with penicillin in humans

Andrew Saxon, Daniel C. Adelman, Richard Hajdu,

Journal of Allergy and Clinical Immunology

1988

165

Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P<sub>1</sub>) Receptor Agonists with Exceptional Selectivity against S1P<sub>2</sub> and S1P<sub>3</sub>

Zhen Li, Weirong Chen, Jeffrey J. Hale,

Journal of Medicinal Chemistry

2005

99

A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists

Jeffrey J. Hale, Christopher L. Lynch, William Neway,

Journal of Medicinal Chemistry

2004

88

Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720

Jeffrey J. Hale, William Neway, Sander G. Mills,

Bioorganic & Medicinal Chemistry Letters

2004

73

1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1–3 (HIF PHD1–3) for the Treatment of Anemia

Petr Váchal, Shouwu Miao, Joan M. Pierce,

Journal of Medicinal Chemistry

2012

66

Page 1